RoccoMorgan Stanley Wealth ManagementNew YorkNew York - NYC (High Net Worth)$2.5M$1.7B$3-25M$3-15MMichelle HansonMerrill Wealth ManagementNew YorkNew York - NYC (High Net Worth)$500K$1.1B$1-100M$500K-50MChristopher MestlMorgan Stanley Wealth ManagementNew YorkNew York - NYC (High Net Worth)$2M$859M$20-100M$5-125MNicholas CarrielloMerrill Wealth ManagementNew YorkNew York - NYC (High Net Worth)$500K$808M$3-10M$3-6MElyssa Coleman-PolsterMerrill Wealth ManagementNew YorkNew York - NYC (High Net Worth)$1M$898M$2.5-20M$1-10MJim DiNardoPioneer Financial | Northwestern MutualNew YorkNew York - NYC (High Net Worth)$750K$2.9B$10-100M$5-25MKevin LuchettaPioneer Financial | Northwestern MutualNew YorkNew York - NYC (High Net Worth)$750K$2.9B$10-100M$5-25MEric HernandezMorgan Stanley Wealth ManagementNew YorkNew York - NYC (High Net Worth)$1M$1.8B$3-30M$1-5MTravis O'BrienMerrill Wealth ManagementNew YorkNew York - NYC (High Net Worth)$5M$6.7B$10-100M$10-25MProfile SpotlightMote ZawalunowJ.P

The two are different molecules, act on different receptors, were developed toward different goals, and sit on opposite ends of the evidence and regulatory spectrum
Aesthetics Professional Aesthetics & Non-surgical Treatments Aesthetics & Non-surgical Treatments At Glam Master we offer a wide range of non-surgical & Aesthetic procedures
We applied our stage-based development approach to evaluate the potential of Hot Melt Extrusion (HME) for one such molecule, delivering measurable improvements including: Reduction in drug dosage Reduction in pill burden Doubled shelf life Improved patient experience without sacrificing performance Want to see how we achieved it, and what it took to get there
In comparison to other GLP-1RAs, semaglutide was found to produce up to three times higher weight loss in type 2 diabetic patients and up to twice as much weight loss in obese patients, with some patients losing up to 15 kg
This is significant because it offers a dual benefit for diabetic patients who are at high risk of kidney disease